ICAAC, 53rd (2013)

Title Content type
Conventional amphotericin B (AMB) activity against Aspergillus species in an in vitro pharmacokinetic (PK)-pharmacodynamic(PD) model (click for details)
Impact of Candida species on the Isavuconazole (ISA) Pharmacodynamic (PD) Target in an in vivo Neutropenic Murine Model of Invasive Candidiasis (IC) (click for details)
Disseminated Histoplasmosis in Costa Rica and the Use of Amphotericin B deoxycholate and Fluconazole as First Line of Theraphy (click for details)
Safety, Tolerability, and Pharmacokinetics of Posaconazole Oral Suspension in Neutropenic Children (click for details)
Different Doses of Micafungin for Prophylaxis of Invasive Fungal Diseases: A Web-based Non-Interventional Trial in Four Large University Hospitals in Germany (click for details)
Caspofungin as Salvage Treatment in Immunocompromised Patients with Pneumocystis Jiroveci Pneumonia (PCP) (click for details)
Population Pharmacokinetic (PK) Analysis of Voriconazole (VOR) and Anidulafungin (ANID) in Adult Patients wiht Invasive Aspergillosis (IA) (click for details)
Activity of Isavuconazole and Comparator Antifungals Tested Against Contemporary (2012) Fungal Clinical Isolates Collected Worldwide (click for details)
A Retrospective Case Control Review Evaluating the Safety and Efficacy of Anidulafungin versus Caspofungin in Individuals with Hepatic Dysfunction Including Liver Transplant Recipients (click for details)
Pharmacokinetics of Caspofungin in Intensive Care Unit Patients (click for details)

Pages

Subscribe to ICAAC, 53rd (2013)